We are live on
!
Find out more
DCM
DAFNA Capital Management Portfolio holdings
AUM
$440M
1-Year Est. Return
109.12%
This Fund
S&P 500
This Quarter
Est. Return
+36.72%
1 Year Est. Return
+109.12%
3 Year Est. Return
+239.59%
5 Year Est. Return
+227.89%
10 Year Est. Return
+3,611.91%
AUM
$405M
AUM Growth
+$42.5M
(+12%)
Cap. Flow
-$59.3M
Cap. Flow
% of AUM
-14.64%
Top 10 Holdings %
Top 10 Hldgs %
57.09%
Holding
83
New
7
Increased
10
Reduced
24
Closed
8
Top Buys
| 1 |
SLNO
Soleno Therapeutics
SLNO
|
+$3.93M |
| 2 |
Larimar Therapeutics
LRMR
|
+$2.46M |
| 3 |
ARS Pharmaceuticals
SPRY
|
+$2.02M |
| 4 |
Inspire Medical Systems
INSP
|
+$1.74M |
| 5 |
Aquestive Therapeutics
AQST
|
+$1.6M |
Top Sells
| 1 |
BPMC
Blueprint Medicines
BPMC
|
+$21.6M |
| 2 |
MRUS
Merus
MRUS
|
+$11.6M |
| 3 |
Ascendis Pharma A/S
ASND
|
+$7.37M |
| 4 |
Mineralys Therapeutics
MLYS
|
+$6.23M |
| 5 |
UroGen Pharma
URGN
|
+$5.78M |
Sector Composition
| 1 | Healthcare | 85.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Stereotaxis
STXS
$160M
| $42.5M | 10.51% |
13,680,554
| – | – |
|
2
State Street SPDR S&P Biotech ETF
XBI
$10.5B
| $40.2M | 9.94% |
401,505
-14,000
| -3% | -$1.26M |
|
3
Revolution Medicines
RVMD
$39.3B
| $30.7M | 7.58% |
657,176
-20,000
| -3% | -$783K |
|
4
Cytokinetics
CYTK
$11.2B
| $21.7M | 5.36% |
394,940
-3,160
| -0.8% | -$130K |
|
5
AtriCure
ATRC
$1.75B
| $20.9M | 5.16% |
592,273
| – | – |
|
|
MRUS
6
DELISTED
Merus
MRUS
| $20.8M | 5.13% |
220,451
-178,353
| -45% | -$11.6M |
|
7
iShares Biotechnology ETF
IBB
$9.23B
| $14.8M | 3.66% |
102,500
| – | – |
|
8
IDEAYA Biosciences
IDYA
$3.55B
| $14.7M | 3.63% |
539,923
-79,167
| -13% | -$1.91M |
|
9
Axogen
AXGN
$2.05B
| $13.2M | 3.27% |
742,282
+500
| +0.1% | +$7.25K |
|
10
Xenon Pharmaceuticals
XENE
$6.55B
| $11.6M | 2.86% |
287,939
| – | – |
|
11
Neurocrine Biosciences
NBIX
$17.2B
| $9.91M | 2.45% |
70,615
| – | – |
|
12
Arcus Biosciences
RCUS
$3.51B
| $8.54M | 2.11% |
627,626
| – | – |
|
13
Syndax Pharmaceuticals
SNDX
$2.08B
| $7.7M | 1.9% |
500,702
-42,900
| -8% | -$562K |
|
|
DAWN
14
DELISTED
Day One Biopharmaceuticals
DAWN
| $7.04M | 1.74% |
999,163
+120,000
| +14% | +$826K |
|
|
15
Ascendis Pharma A/S
ASND
$17.5B
| $6.6M | 1.63% |
33,177
-39,500
| -54% | -$7.37M |
|
|
KALV
16
DELISTED
KalVista Pharmaceuticals
KALV
| $5.15M | 1.27% |
422,731
-159,026
| -27% | -$2.2M |
|
|
BCAX
17
Bicara Therapeutics
BCAX
$1.83B
| $5.01M | 1.24% |
317,001
| – | – |
|
18
Inogen
INGN
$174M
| $4.95M | 1.22% |
605,625
| – | – |
|
|
CMPS
19
Compass Pathways
CMPS
$1.8B
| $4.65M | 1.15% |
811,046
| – | – |
|
|
LKFT
20
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.94B
| $4.51M | 1.11% |
130,175
| – | – |
|
21
DexCom
DXCM
$28.4B
| $4.41M | 1.09% |
65,552
| – | – |
|
22
Tandem Diabetes Care
TNDM
$1.06B
| $4.31M | 1.07% |
355,208
+61,000
| +21% | +$826K |
|
23
Kura Oncology
KURA
$1B
| $4.1M | 1.01% |
463,368
| – | – |
|
24
Alkermes
ALKS
$8.68B
| $4.04M | 1% |
134,748
+31,000
| +30% | +$874K |
|
25
Stoke Therapeutics
STOK
$1.87B
| $3.99M | 0.99% |
169,791
-332,181
| -66% | -$5.69M |
|
Similar funds
FGWP
STCG
SCP
CAAM
AWM
HCM
CPW
DWML